#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17004	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2114	799.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1458	1458	C	1028	C	946	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31372	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3560	878.4	0	.	n	.	0	T695C	SNP	695	695	T	992	992	C	970	C	906	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31372	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3560	878.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1634	1634	A	1040	A	950	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31372	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3560	878.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2268	2268	C	1005	C	910	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31372	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3560	878.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2342	2342	A	1019	A	937	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	31372	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3560	878.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2894	2894	C	1003	C,T	936,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2130	folP	852	852	100.0	folP.l15.c4.ctg.1	1515	140.1	1	SNP	p	R228S	1	.	.	682	684	AGC	1009	1011	AGC	227;230;227	A;G;C	206;205;204	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5614	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3538	158.1	1	SNP	p	S91F	0	.	.	271	273	TCC	569	571	TCC	212;212;214	T;C;C	199;201;201	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5614	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3538	158.1	1	SNP	p	D95G	0	.	.	283	285	GAC	581	583	GAC	207;206;207	G;A;C	192;191;194	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5614	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3538	158.1	1	SNP	p	D95N	0	.	.	283	285	GAC	581	583	GAC	207;206;207	G;A;C	192;191;194	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1438	117.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	522	524	ACC	182;183;180	A;C;C	161;168;165	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1438	117.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	537	539	CAC	186;189;191	C;A;C	170;167;175	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1438	117.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	720	722	CAC	226;222;225	C;A;C	211;206;210	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1696	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1438	117.6	1	SNP	p	G45D	0	.	.	133	135	GGC	540	542	GGC	189;189;190	G;G;C	173;173;175	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	980	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	957	101.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2989	191.3	1	SNP	p	D86N	0	.	.	256	258	GAC	697	699	GAC	248;248;248	G;A;C	227;228;229	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2989	191.3	1	SNP	p	S87R	0	.	.	259	261	AGT	700	702	AGT	248;247;248	A;G;T,C	230;230;231,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2989	191.3	1	SNP	p	S87I	0	.	.	259	261	AGT	700	702	AGT	248;247;248	A;G;T,C	230;230;231,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2989	191.3	1	SNP	p	S87W	0	.	.	259	261	AGT	700	702	AGT	248;247;248	A;G;T,C	230;230;231,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2989	191.3	1	SNP	p	S88P	0	.	.	262	264	TCC	703	705	TCC	251;254;254	T,C;C;C	235,1;234;235	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4546	parE	1986	1986	100.0	parE.l6.c30.ctg.1	2721	166.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1565	1567	GGC	222;218;217	G;G;C	196;193;191	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1253	1255	GCA	268;268;273	G;C;A	241;245;250	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1256	1258	ATC	274;274;278	A;T;C	251;252;257	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1268	1270	GTG	271;271;274	G;T;G	253;252;255	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1268	1270	GTG	271;271;274	G;T;G	253;252;255	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1772	1774	ACC	224;222;222	A,C;C;C	197,1;201;201	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1826	1828	GCG	205;206;206	G;C,T;G	181;176,1;178	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1826	1828	GCG	205;206;206	G;C,T;G	181;176,1;178	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1949	1951	GGC	190;189;191	G;G;C	170;168;172	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1958	1960	GGC	176;175;173	G;G;C,A	150;148;149,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2349	188.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1976	1978	CCG	148;147;153	C,G;C;G,C,T	109,6;106;108,1,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	6244	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3094	201.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1626	1628	CTG	248;248;247	C;T;G	217;215;216	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2400	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1760	135.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	567	567	C	160	C	151	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3150	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1472	212.5	0	.	p	.	0	R40Q	NONSYN	118	120	CGG	403	405	CAG	258;258;261	C;A,G;G	233;235,1;239	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3150	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1472	212.5	0	.	p	.	0	E48G	NONSYN	142	144	GAA	427	429	GGA	276;271;270	G;G;A	251;245;249	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3150	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1472	212.5	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	916	916	T	274	T	250	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3150	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1472	212.5	1	SNP	p	G120K	0	.	.	358	360	GGT	643	645	GGT	255;259;258	G;G;T	236;240;235	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3150	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1472	212.5	1	SNP	p	A121D	0	.	.	361	363	GCC	646	648	GCC	260;256;256	G;C;C	237;235;235	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3150	porB1b	1035	1035	98.57	porB1b.l15.c4.ctg.1	1472	212.5	1	SNP	p	A121N	0	.	.	361	363	GCC	646	648	GCC	260;256;256	G;C;C	237;235;235	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11610	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4902	236.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1386	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1016	135.8	1	SNP	p	V57M	1	.	.	169	171	ATG	571	573	ATG	296;298;300	A;T;G,T	260;259;263,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
